Faricimab is a medication used to treat diabetic macular edema, which is a condition where fluid builds up in the macula (central part of the retina) due to diabetes. This medicine works by targeting and blocking two different pathways that cause blood vessels to leak and grow abnormally in the eye. It is administered as an injection directly into the eye by a healthcare professional. The medication helps improve vision and reduce swelling in patients with diabetic macular edema.

Macular Edema – A condition where fluid accumulates in the macula, the central part of the retina responsible for detailed vision. The buildup of fluid causes the macula to swell and thicken, which distorts vision in the center of the visual field. This condition commonly occurs as a complication of diabetes, where it is specifically known as diabetic macular edema. The swelling can lead to blurred or distorted central vision, while peripheral vision typically remains unchanged. As the condition progresses, it may cause difficulty with reading, recognizing faces, or performing detailed tasks.

Diabetic Macular Edema – A specific type of macular edema that occurs in people with diabetes when damaged blood vessels in the retina begin to leak fluid into the macula. The condition develops when high blood sugar levels damage the tiny blood vessels in the retina, causing them to become weak and permeable. As these vessels leak fluid into the macula, the central part of the retina swells, leading to vision problems. The condition typically develops gradually and affects both eyes, though not necessarily at the same rate or severity.